NCT02727803 2025-11-06Personalized NK Cell Therapy in CBTM.D. Anderson Cancer CenterPhase 2 Recruiting100 enrolled
NCT06453902 2025-02-21TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) PatientsShenzhen TargetRx, Inc.Phase 2 Recruiting40 enrolled